These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23709619)

  • 21. Pandemic (avian) influenza.
    Rajagopal S; Treanor J
    Semin Respir Crit Care Med; 2007 Apr; 28(2):159-70. PubMed ID: 17458770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From Variation of Influenza Viral Proteins to Vaccine Development.
    Zhu W; Wang C; Wang BZ
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of influenza vaccine strains and developing pandemic vaccines.
    Wood JM
    Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aflunov(®): a prepandemic influenza vaccine.
    Gasparini R; Amicizia D; Lai PL; Panatto D
    Expert Rev Vaccines; 2012 Feb; 11(2):145-57. PubMed ID: 22309663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza and Influenza Vaccine: A Review.
    Nypaver C; Dehlinger C; Carter C
    J Midwifery Womens Health; 2021 Jan; 66(1):45-53. PubMed ID: 33522695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Planning for the next pandemic of influenza.
    Gust ID; Hampson AW; Lavanchy D
    Rev Med Virol; 2001; 11(1):59-70. PubMed ID: 11241802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines against epidemic and pandemic influenza.
    Hoelscher M; Gangappa S; Zhong W; Jayashankar L; Sambhara S
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1139-57. PubMed ID: 18817518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.
    Hilleman MR
    Vaccine; 2002 Aug; 20(25-26):3068-87. PubMed ID: 12163258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza.
    Stamboulian D; Bonvehí PE; Nacinovich FM; Cox N
    Infect Dis Clin North Am; 2000 Mar; 14(1):141-66. PubMed ID: 10738677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines.
    Biswas A; Chakrabarti AK; Dutta S
    Int Rev Immunol; 2020; 39(1):21-36. PubMed ID: 31707873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategic analysis on responding human avian flu and flu pandemic in China.
    Zeng G
    Biomed Environ Sci; 2006 Apr; 19(2):158-61. PubMed ID: 16827190
    [No Abstract]   [Full Text] [Related]  

  • 32. L-carnosine modulates respiratory burst and reactive oxygen species production in neutrophil biochemistry and function: may oral dosage form of non-hydrolized dipeptide L-carnosine complement anti-infective anti-influenza flu treatment, prevention and self-care as an alternative to the conventional vaccination?
    Babizhayev MA; Deyev AI; Yegorov YE
    Curr Clin Pharmacol; 2014 May; 9(2):93-115. PubMed ID: 23441838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.
    Ford SM; Grabenstein JD
    Pharmacotherapy; 2006 Mar; 26(3):312-22. PubMed ID: 16503711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study.
    Ghosh S; Heffernan J
    PLoS One; 2010 Dec; 5(12):e14307. PubMed ID: 21187938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza.
    Swayne DE; Spackman E
    Dev Biol (Basel); 2013; 135():79-94. PubMed ID: 23689886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research progress in human infection with avian influenza H7N9 virus.
    Tang J; Wang D
    Sci China Life Sci; 2017 Dec; 60(12):1299-1306. PubMed ID: 29270791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017.
    Kile JC; Ren R; Liu L; Greene CM; Roguski K; Iuliano AD; Jang Y; Jones J; Thor S; Song Y; Zhou S; Trock SC; Dugan V; Wentworth DE; Levine MZ; Uyeki TM; Katz JM; Jernigan DB; Olsen SJ; Fry AM; Azziz-Baumgartner E; Davis CT
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(35):928-932. PubMed ID: 28880856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine.
    Krammer F; García-Sastre A; Palese P
    Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.